Aquaron (AQUNU) Prices $50M IPO
by Marlena Haddad on 2022-10-04 at 6:33am

Aquaron Acquisition Corp. priced its $50 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “AQUNU” Tuesday, October 4, 2022.

The new SPAC intends to identify targets in the new energy sector that are based in the U.S. or Asia with a total enterprise value between $150 million and $300 million. Aquaron is led by CEO, Chairwoman, and President Yi Zhou and CFO Qingze Zhao.

Total SPAC deal count for 2022 year-to-date is now 79. This offering is expected to close on Thursday, October 6.


Chardan is the sole book-running manager for the offering. Wilson Sonsini Goodrich & Rosati is serving as Issuer’s Counsel with Reed Smith LLP serving as Underwriter’s Counsel. UHY, LLP serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.

Recent Posts
by Nicholas Alan Clayton on 2024-02-23 at 2:26pm

Pyrophyte (NYSE:PHYT) faced a major regulatory setback for its combination with mining firm Sio Silica this week, but a recent analogous SPAC deal could provide some encouragement for a path forward. Sio Silica is working to develop a high-grade silica mine in the Vivian Sands outside Winnipeg, Canada and it inked the $708 million combination...

by Nicholas Alan Clayton on 2024-02-23 at 1:37pm

News and Rumors JD Supra: Securities class action lawsuits against SPACs and de-SPACs increased only slightly in 2023 with 27 after 2022 saw 24 and 2021 – 33. Lawsuits concerning the de-SPACing process itself dropped precipitously, however, representing just 21% of cases as compared to 69% in the previous two years and 80% in 2020....

by Nicholas Alan Clayton on 2024-02-23 at 7:39am

At the SPAC of Dawn SPACs have officially landed on the Moon. Despite a few last-minute delays and minor malfunctions, Intuitive Machines’ (NASDAQ:LUNR) Odysseus lander made the first soft landing on the Moon since 1972 and the first ever by a commercial enterprise. Three other private missions to the moon have failed in recent years...

by Nicholas Alan Clayton on 2024-02-22 at 2:50pm

Moringa (NASDAQ:MACA) has entered into a definitive agreement to combine with clinical-stage biotech firm Silexion at a pre-transaction equity value of $62.5 million. Modi’in-Maccabim-Reut, Israel-based Silexion is developing a range of potential cancer treatments with its most advanced efforts targeting pancreatic cancer. The combined company is expected to trade on the Nasdaq once the deal...

by Nicholas Alan Clayton on 2024-02-22 at 1:32pm

News and Rumors CityWire: A subsidiary of Allianz (DE:ALV) and Constellation Wealth Capital have signed on to invest $400 million in asset management firm AlTi Global (NASDAQ:ALTI), purchasing a combination of ordinary shares and Series A convertible preferred stock. AlTi is up 21% in midday trading on the news. It combined with Cartesian Growth in...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved